Skip to content

Acebutolol

beta-Adrenergic Blocker — CARDIOVASCULAR SYSTEM

Also known as: (+/-)-Acebutolol, (RS)-Acebutolol, acebutolol HCl, acebutolol hydrochloride, dl-Acebutolol, IL-17803A

OfpFDA approvedATC C07AB04ATC C07BB04

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Acebutolol is an ofp drug in the beta-Adrenergic Blocker class catalogued in DrugCentral. It was first approved by the FDA in 1984. Its mechanism of action is classified as Adrenergic beta-Antagonists. DrugCentral lists 3 molecular targets, including ADRB1, ADRB2 and Htr1a. Recorded indications include Hypertensive disorder and Ventricular premature beats.

  • Approval status: ofp (first approved 1984 by the FDA).
  • Drug class: beta-Adrenergic Blocker.
  • Mechanism of action: Adrenergic beta-Antagonists.
  • Molecular targets: ADRB1, ADRB2 and Htr1a (3 listed in DrugCentral).
  • Indications: Hypertensive disorder and Ventricular premature beats.
  • ATC code: C07AB04 (Beta blocking agents, selective).
  • Molecular formula: C18H28N2O4; molecular weight 336.43 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Hypertensive disorder
  • Ventricular premature beats

Off-label uses (5)

  • Angina pectoris
  • Anxiety
  • Mitral valve prolapse
  • Myocardial Reinfarction Prevention
  • Thyrotoxicosis

Contraindications (22)

  • Acute exacerbation of asthma
  • Anaphylaxis
  • Asthma
  • Cardiogenic shock
  • Complete atrioventricular block
  • Decompensated cardiac failure
  • Depressive disorder
  • Diabetes mellitus
  • Disease of liver
  • Kidney disease
  • Myasthenia gravis
  • Partial atrioventricular block
  • Peripheral arterial occlusive disease
  • Peripheral vascular disease
  • Pheochromocytoma
  • Pregnancy, function
  • Psoriasis
  • Pulmonary emphysema
  • Raynaud's phenomenon
  • Severe chronic obstructive pulmonary disease
  • Sick sinus syndrome
  • Sinus bradycardia

Mechanism & targets

Mechanism of action (MoA)Adrenergic beta-Antagonists
Established pharmacologic classbeta-Adrenergic Blocker

Molecular targets (3)

TargetGeneActionActivity
Beta-1 adrenergic receptorADRB1antagonistKi 7.30
Beta-2 adrenergic receptorADRB2unknownKi 6.40
5-hydroxytryptamine receptor 1AHtr1aunknownKi 5.00

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1984-12-28FDA—PROMIUS PHARMA

ATC classification

ATC codeTherapeutic hierarchy
C07AB04CARDIOVASCULAR SYSTEM › BETA BLOCKING AGENTS › BETA BLOCKING AGENTS › Beta blocking agents, selective
C07BB04CARDIOVASCULAR SYSTEM › BETA BLOCKING AGENTS › BETA BLOCKING AGENTS AND THIAZIDES › Beta blocking agents, selective, and thiazides

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Sedation complication1819.7
Creatinine renal clearance decreased1805.2
Cognitive disorder1727.7
Orthostatic hypotension1678.2
Blood calcium decreased1567.3
Sedation1521.5
Balance disorder1369.2
Depressed level of consciousness1140.7
Hypotension859.3
Mobility decreased832.1
Constipation795.8
Fall735.4

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Acebutolol is on its molecule page.

Molecular formulaC18H28N2O4
Molecular weight336.43 g/mol
CAS number37517-30-9
InChIKeyGOEMGAFJFRBGGG-UHFFFAOYSA-N
PubChem CID1978
CCCC(=O)NC1=CC(C(C)=O)=C(OCC(O)CNC(C)C)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Acebutolol used for?

DrugCentral lists the following indications for Acebutolol: Hypertensive disorder and Ventricular premature beats.

How does Acebutolol work?

Acebutolol is classified as Adrenergic beta-Antagonists; its molecular targets in DrugCentral include ADRB1 (antagonist), ADRB2 and Htr1a.

When was Acebutolol first approved?

Acebutolol was first approved by the FDA in 1984.

What drug class does Acebutolol belong to?

Acebutolol is in the beta-Adrenergic Blocker class.

What is the chemical formula of Acebutolol?

Acebutolol has the molecular formula C18H28N2O4 and a molecular weight of 336.43 g/mol.

Browse: all drugs starting with A · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1984-12-28
AgencyFDA
Targets3
Indications2
FormulaC18H28N2O4
DrugCentral ID40
Interactive profile